Curis | CRIS - Current Assets


Curis reported $14.42M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
CSL USD 11.85B 1000K Dec/2025
Curis USD 14.42M 10.39M Jun/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Exelixis USD 1.44B 41.03M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Takeda JPY 3.12T 195.82B Dec/2025
TG Therapeutics USD 630.76M 31M Dec/2025
Verastem USD 154.06M 29.36M Sep/2025
Xoma USD 110.71M 5.78M Sep/2025